A novel model of pneumonia from intraperitoneal injection of bacteria

Glen A Franklin1, Melanie J Scott, Manoj Patel

  • 1Veterans Affairs Medical Center, and Department of Surgery, University of Louisville, 2nd Floor ACB, Louisville, KY 40292, USA. glen.franklin@louisville.edu

Abstract

Insights

Intraperitoneal Klebsiella pneumoniae injection in mice uniformly causes pneumonia, unlike intravenous administration. This reproducible model allows for manipulation of severity, aiding pneumonia research in surgical patients.

Area of Science:

  • Microbiology
  • Immunology
  • Surgical Pathology

Background:

  • Pneumonia is a significant complication in surgical patients.
  • Current experimental models for pneumonia lack reproducibility.
  • An attempt to model peritonitis led to the discovery of a novel pneumonia model.

Purpose of the Study:

  • To develop and validate a reproducible experimental model for studying pneumonia.
  • To investigate the effects of Klebsiella pneumoniae administration via different routes.

Main Methods:

  • Male Swiss Webster mice received intraperitoneal (IP) or intravenous (IV) injections of Klebsiella pneumoniae.
  • Bacterial doses were varied, and survival curves were generated.
  • Blood, peritoneal fluid, and lung tissue were analyzed for bacterial load, lung weight, and myeloperoxidase levels.

Main Results:

  • IP Klebsiella pneumoniae was uniformly lethal, causing pneumonia and bacteremia within 24 hours.
  • IV administration resulted in higher survival rates, with successful bacterial clearance.
  • A dose-dependent relationship was observed, with increased lung weight and bacterial levels in the lungs after IP injection.

Conclusions:

  • The IP Klebsiella pneumoniae model reliably induces pneumonia, not peritonitis, in mice.
  • This model is reproducible, simple, and allows for adjustable severity.
  • Findings correlate bacterial load with disease progression, offering a valuable tool for pneumonia research.